ANTX
Price
$1.05
Change
-$0.00 (-0.00%)
Updated
Aug 14 closing price
Capitalization
28.83M
83 days until earnings call
NKTX
Price
$2.20
Change
-$0.01 (-0.45%)
Updated
Aug 14 closing price
Capitalization
156.25M
82 days until earnings call
Interact to see
Advertisement

ANTX vs NKTX

Header iconANTX vs NKTX Comparison
Open Charts ANTX vs NKTXBanner chart's image
AN2 Therapeutics
Price$1.05
Change-$0.00 (-0.00%)
Volume$73.99K
Capitalization28.83M
Nkarta
Price$2.20
Change-$0.01 (-0.45%)
Volume$827.61K
Capitalization156.25M
ANTX vs NKTX Comparison Chart in %
Loading...
ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANTX vs. NKTX commentary
Aug 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANTX is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2025
Stock price -- (ANTX: $1.05 vs. NKTX: $2.20)
Brand notoriety: ANTX and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANTX: 46% vs. NKTX: 153%
Market capitalization -- ANTX: $28.83M vs. NKTX: $156.25M
ANTX [@Biotechnology] is valued at $28.83M. NKTX’s [@Biotechnology] market capitalization is $156.25M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.07B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANTX’s FA Score shows that 1 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • ANTX’s FA Score: 1 green, 4 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than ANTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANTX’s TA Score shows that 2 TA indicator(s) are bullish while NKTX’s TA Score has 6 bullish TA indicator(s).

  • ANTX’s TA Score: 2 bullish, 6 bearish.
  • NKTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than ANTX.

Price Growth

ANTX (@Biotechnology) experienced а -2.31% price change this week, while NKTX (@Biotechnology) price change was +9.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.69%. For the same industry, the average monthly price growth was +27.47%, and the average quarterly price growth was +19.86%.

Reported Earning Dates

ANTX is expected to report earnings on Nov 06, 2025.

NKTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($156M) has a higher market cap than ANTX($28.8M). NKTX YTD gains are higher at: -11.647 vs. ANTX (-23.551). ANTX has higher annual earnings (EBITDA): -47.8M vs. NKTX (-122.8M). NKTX has more cash in the bank: 266M vs. ANTX (67.1M). ANTX (0) and NKTX (0) have equivalent revenues.
ANTXNKTXANTX / NKTX
Capitalization28.8M156M18%
EBITDA-47.8M-122.8M39%
Gain YTD-23.551-11.647202%
P/E RatioN/AN/A-
Revenue00-
Total Cash67.1M266M25%
Total DebtN/A78.9M-
FUNDAMENTALS RATINGS
ANTX: Fundamental Ratings
ANTX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
76
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANTXNKTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
84%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BFLBF107.60N/A
N/A
Bilfinger SE
KONMY88.21N/A
N/A
Konami Group Corporation
MXLLF12.76N/A
N/A
MAXELL LTD.
RGTLF0.05N/A
N/A
Argent BioPharma Limited
PYRGF0.27-0.01
-3.03%
PYROGENESIS INC.

ANTX and

Correlation & Price change

A.I.dvisor tells us that ANTX and ATNM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANTX and ATNM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANTX
1D Price
Change %
ANTX100%
+0.48%
ATNM - ANTX
29%
Poorly correlated
+3.12%
PHAR - ANTX
28%
Poorly correlated
+1.16%
NKTX - ANTX
26%
Poorly correlated
-0.45%
CSLLY - ANTX
26%
Poorly correlated
-1.23%
ZVRA - ANTX
26%
Poorly correlated
-5.62%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-0.45%
FATE - NKTX
49%
Loosely correlated
-5.31%
BEAM - NKTX
49%
Loosely correlated
+0.63%
CRBU - NKTX
47%
Loosely correlated
+2.56%
SYRE - NKTX
45%
Loosely correlated
-3.10%
TERN - NKTX
44%
Loosely correlated
+4.31%
More